REG - Brand Architekts Grp - Directorate Changes

Brand ArchitektsAnnouncement

26/05/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230526:nRSZ7339Aa&default-theme=true

RNS Number : 7339A  Brand Architekts Group PLC  26 May 2023

26 May 2023

 

Brand Architekts Group PLC

("Brand Architekts" or the "Group")

Directorate Changes

Brand Architekts Group plc, a challenger British Beauty brand business, is
pleased to announce the appointment of Geoff Ellis to the Board as Chief
Financial Officer with effect from 3 July on a part-time basis.

Geoff has had a distinguished career as an experienced Chief Financial Officer
& Chief Operational Officer, with consistent achievement in international
business development, combined with expertise in post-merger integration and
restructuring. Geoff is a chartered accountant and previously was CFO at
Proteome PLC. Between 1995 and 2009 Geoff held a variety of senior executive
roles at Walt Disney Incorporated. Charlotte Lee, Group Financial Controller,
who has been with the Group for 3 years, will support Geoff in his role.

Tom Carter will leave the business on 30 June, after overseeing an extensive
handover in May and June with Geoff. Tom has been instrumental in putting in
place the appropriate systems, procedures and finance structure, which has
resulted in efficiency and financial governance improvements.

Simon Pyper will stand down from the Board, with effect from 31 May, in order
to focus on his role as Chief Executive Officer of CPP Group PLC. Simon has
played a key role in integrating Innovaderma into the Group and the board
thanks him for his contribution. Amy Nelson- Bennett will become chair of the
audit committee.

The Group remains focussed on improving profit and cash generation by
developing its Invest (Skinny Tan and Super Facialist) and Nurture (Dirty
Works and The Solution) portfolio of brands, thereby engendering strong
consumer loyalty and stronger margins by delivering highly efficacious
problem-solving beauty solutions. The Group is on track to deliver the
operating synergies outlined as part of the Innovaderma acquisition.

Roger McDowell, Chairman, said:

'I am delighted to welcome Geoff to the board and look forward to working
together. I would also like to extend the board's thanks to Tom. Tom made a
very positive impact on the business and leaves with our best wishes. Finally,
I would like to thank Simon for his contribution, particularly his assistance
with the Innovaderma integration. The board remain committed to developing our
key brands and creating value for our shareholders.'

Additional Information:

Geoffrey John Ellis (aged 62) is, or has been, a director or partner of the
following companies or partnerships during the previous five years:

 Current directorships/partnerships                                 Past directorships (last 5 years)
 ·      National Counties Cricket Association Limited               None

 ·      Esher Cricket Club Property Companies No. 1 Limited

 ·      Esher Cricket Club Property Companies No. 2 Limited

 

Geoff has no beneficial interest in the equity securities of Brand Architekts
plc.

Save as set out above there are no other disclosures in respect of the
appointment of Geoff Ellis that fall to be made under Rule 17 or paragraph (g)
of Schedule Two of the AIM Rules for Companies.

 

 For further information please contact:

 Brand Architekts Group PLC

 Quentin Higham

 Singer Capital Markets      (Nominated adviser and broker)  020 7496 3000

 Shaun Dobson / Jen Boorer
 Alma PR                                                     0203 405 0205

 Josh Royston / Sam Modlin

 

This announcement contains inside information for the purposes of Article 7 of
Regulation (EU) No 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEAPSSAFXDEFA